Amanta Healthcare Limited — Salbutamol Exporter Profile
Indian Pharmaceutical Exporter · #7 for Salbutamol · $2.0M export value · DGFT Verified
Amanta Healthcare Limited is the #7 Indian exporter of Salbutamol with $2.0M in export value and 43 verified shipments. Amanta Healthcare Limited holds a 1.3% market share in Salbutamol exports across 4 countries. The company exports 2 pharmaceutical products worth $6.4M across 2 therapeutic categories.
Amanta Healthcare Limited — Salbutamol Export Profile: Buyers & Destinations
Where Does Amanta Healthcare Limited Export Salbutamol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.2M | 28 | 90.4% |
| THAILAND | $59.3K | 2 | 4.5% |
| KENYA | $48.4K | 12 | 3.6% |
| VIETNAM, DEMOCRATIC REP. OF | $20.2K | 1 | 1.5% |
Amanta Healthcare Limited exports Salbutamol to 4 countries. The largest destination is PHILIPPINES accounting for 90.4% of Amanta Healthcare Limited's Salbutamol shipments, followed by THAILAND (4.5%) and KENYA (3.6%). These destinations reflect Amanta Healthcare Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Salbutamol from Amanta Healthcare Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF CHINA BANKING CORPO | PHILIPPINES | $200.0K | 4 |
| TO THE ORDER OF CHINA BANKING | PHILIPPINES | $187.1K | 4 |
| TO THE ORDER OF METROPOLITAN BANK A | PHILIPPINES | $150.0K | 3 |
| TO THE ORDER | PHILIPPINES | $150.0K | 3 |
| TO THE ORDER OF.,,,, | PHILIPPINES | $135.7K | 3 |
| TO THE ORDER OF ASIA UNITED BANK | PHILIPPINES | $107.2K | 3 |
| PINYO PHARMACY LTD.,PART | THAILAND | $59.3K | 2 |
| CHINA BANKING CORPORATION | PHILIPPINES | $50.0K | 1 |
| TO THE ORDER OF BANK OF,.,., | PHILIPPINES | $50.0K | 1 |
| TO THE ORDER OF ASIA | PHILIPPINES | $50.0K | 1 |
Amanta Healthcare Limited supplies Salbutamol to 20 buyers globally. The largest buyer is TO THE ORDER OF CHINA BANKING CORPO (PHILIPPINES), followed by TO THE ORDER OF CHINA BANKING (PHILIPPINES) and TO THE ORDER OF METROPOLITAN BANK A (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Salbutamol Export Value and How Much Does Amanta Healthcare Limited Contribute?
India exported $130.8M worth of Salbutamol through 14,359 shipments from 602 suppliers to 164 countries, serving 1,775 buyers globally. Amanta Healthcare Limited contributes $2.0M to this total, accounting for 1.3% of India's Salbutamol exports. Amanta Healthcare Limited ships Salbutamol to 4 countries through 20 buyers.
What Is the Average Shipment Value for Amanta Healthcare Limited's Salbutamol Exports?
Amanta Healthcare Limited's average Salbutamol shipment value is $46.3K per consignment, based on 43 shipments totaling $2.0M. The largest destination is PHILIPPINES (90.4% of Amanta Healthcare Limited's Salbutamol exports).
How Does Amanta Healthcare Limited Compare to Other Indian Salbutamol Exporters?
Amanta Healthcare Limited ranks #7 among 602 Indian Salbutamol exporters with a 1.3% market share. The top 3 exporters are CIPLA LIMITED ($100.3M), GLENMARK PHARMACEUTICALS LIMITED ($5.7M), AHLCON PARENTERALS (INDIA) LIMITED ($4.9M). Amanta Healthcare Limited processed 43 shipments to 4 destination countries.
What Salbutamol Formulations Does Amanta Healthcare Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SALBUTAMOL(AS SULFATE)1MG/ML(2.5MG/2.5ML)SOLUTION FOR INHALATION AERO VENT O/D AS PER INVOICE PACKING LISTNOS | $150.0K | 3 |
| SALBUTAMOL ( AS SULFATE ) 1MG/ML ( 2.5MG/2.5ML ) SOLUTION FOR INHALATION-AERO-VENT | $150.0K | 3 |
| SALBUTAMOL ( AS SULFATE ) 1MG/ML ( 2.5MG/2.5ML ) SOLUTION FOR INHALATION ¿ AERO-VENT | $135.7K | 3 |
| PHARMACEUTICAL PRODUCTS SALBUTAMOL (AS S | $100.0K | 2 |
| SALBUTAMOLAS SULFATE1MG/ML2.5MG/2.5ML | $100.0K | 2 |
| SALBUTAMOL NEBULISER SOLUTION B.P. 2.5 M | $59.3K | 2 |
| PHARMACEUTICAL PRODUCTS, SALBUTAMOL (AS | $50.0K | 1 |
| SALBUTAMOL AS SULFATE 1MG ML 2 5MG 2 5ML SOLUTION FOR INHALATION AERO VENTOTHER DETAIL AS PER INVOICE AND PACKING | $50.0K | 1 |
| SALBUTAMOL( AS SULFATE )1MG /ML (2.5MG/2 | $50.0K | 1 |
| SALBUTAMOL(AS SULFATE)1MG/ML(2.5MG/2.5ML | $50.0K | 1 |
Amanta Healthcare Limited exports 30 distinct Salbutamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SALBUTAMOL(AS SULFATE)1MG/ML(2.5MG/2.5ML)SOLUTION FOR INHALA with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Amanta Healthcare Limited Compare to Nearest Salbutamol Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $4.9M | 177 | 2 | $27.5K |
| 6 | EMCURE PHARMACEUTICALS LIMITED | $2.2M | 123 | 14 | $18.1K |
| 7 | AMANTA HEALTHCARE LIMITED ★ | $2.0M | 43 | 4 | $46.3K |
| 8 | MGRM MEDICARE PRIVATE LIMITED | $1.8M | 54 | 1 | $34.2K |
| 9 | CHANDRA BHAGAT PHARMA PRIVATE LIMITED | $1.4M | 40 | 1 | $33.9K |
Amanta Healthcare Limited ranks #7 among 602 Indian Salbutamol exporters. Average shipment value of $46.3K compared to the market average of $217.4K. The closest competitors by value are MEDISPRAY LABORATORIES PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Salbutamol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,198 | 15.3% |
| SAHAR AIR | 2,141 | 14.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,530 | 10.7% |
| NHAVA SHEVA SEA (INNSA1) | 1,497 | 10.4% |
| DELHI AIR | 1,064 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 1,036 | 7.2% |
| JNPT | 842 | 5.9% |
| Bombay Air | 568 | 4.0% |
About Amanta Healthcare Limited
Amanta Healthcare Limited exports 2 products worth $6.4M. Beyond Salbutamol, top products include Metronidazole. View the complete Amanta Healthcare Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salbutamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salbutamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Amanta Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 43 individual customs records matching Amanta Healthcare Limited exporting Salbutamol, covering 30 formulations to 4 countries via 20 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 164+ countries, 1,775+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salbutamol Export Data from Amanta Healthcare Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Amanta Healthcare Limited's Salbutamol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Amanta Healthcare Limited
Full Company Profile →
2 products · $6.4M total trade · 2 categories
Salbutamol Stats
Company Overview
Top Products by Amanta Healthcare Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Amanta Healthcare Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salbutamol. For current shipment-level data, contact TransData Nexus.